US Stock MarketDetailed Quotes

XBIO Xenetic Biosciences

Watchlist
  • 4.2900
  • +0.0100+0.23%
Close Dec 20 16:00 ET
6.62MMarket Cap-1.61P/E (TTM)

Xenetic Biosciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0.50%614.24K
11.58%726.4K
-15.69%510.82K
48.80%2.54M
37.99%671.96K
47.54%611.17K
56.22%651.01K
55.75%605.84K
47.06%1.71M
46.41%486.97K
Operating revenue
0.50%614.24K
11.58%726.4K
-15.69%510.82K
48.80%2.54M
37.99%671.96K
47.54%611.17K
56.22%651.01K
55.75%605.84K
47.06%1.71M
46.41%486.97K
Cost of revenue
Gross profit
Operating expense
-36.64%1.11M
11.61%2.06M
16.98%1.78M
-16.25%7.06M
-5.98%1.93M
39.29%1.76M
-40.42%1.85M
-24.28%1.52M
21.97%8.42M
-7.08%2.05M
Selling and administrative expenses
1.15%745.73K
19.46%1.13M
-9.81%834.91K
-2.55%3.56M
11.06%952K
-14.60%737.24K
-7.83%945.95K
2.03%925.74K
-2.40%3.65M
-12.32%857.17K
-General and administrative expense
1.15%745.73K
19.46%1.13M
-9.81%834.91K
-2.55%3.56M
11.06%952K
-14.60%737.24K
-7.83%945.95K
2.03%925.74K
-2.40%3.65M
-12.32%857.17K
Research and development costs
-63.94%367.99K
3.38%933.77K
58.64%944.32K
-26.75%3.49M
-18.23%975.63K
155.92%1.02M
-56.52%903.24K
-45.95%595.28K
50.81%4.77M
-2.92%1.19M
Operating profit
56.44%-499.47K
-11.62%-1.34M
-38.60%-1.27M
32.78%-4.52M
19.68%-1.26M
-35.26%-1.15M
55.41%-1.2M
43.50%-915.18K
-16.90%-6.72M
16.58%-1.56M
Net non-operating interest income expense
-33.22%61.3K
-49.69%63.45K
35.39%73.25K
112.83%355.76K
4.95%83.76K
101.86%91.8K
689.87%126.1K
108.84%54.1K
66.38%167.15K
171.07%79.81K
Non-operating interest income
-33.22%61.3K
-49.69%63.45K
35.39%73.25K
112.83%355.76K
4.95%83.76K
101.86%91.8K
689.87%126.1K
108.84%54.1K
66.38%167.15K
171.07%79.81K
Other net income (expense)
325.83%1.5K
-100.10%-21
-98.85%52
1,689.23%25.38K
-59.03%404
60.96%-666
2,063.01%21.12K
2,171.36%4.52K
-242.72%-1.6K
-66.04%986
Other non- operating income (expenses)
325.83%1.5K
-100.10%-21
-98.85%52
1,689.23%25.38K
-59.03%404
60.96%-666
2,063.01%21.12K
2,171.36%4.52K
-242.72%-1.6K
-66.04%986
Income before tax
58.63%-436.67K
-21.22%-1.27M
-39.53%-1.2M
36.90%-4.13M
20.98%-1.17M
-31.29%-1.06M
60.67%-1.05M
46.25%-856.55K
-16.07%-6.55M
19.50%-1.48M
Income tax
Net income
58.63%-436.67K
-21.22%-1.27M
-39.53%-1.2M
36.90%-4.13M
20.98%-1.17M
-31.29%-1.06M
60.67%-1.05M
46.25%-856.55K
-16.07%-6.55M
19.50%-1.48M
Net income continuous Operations
58.63%-436.67K
-21.22%-1.27M
-39.53%-1.2M
36.90%-4.13M
20.98%-1.17M
-31.29%-1.06M
60.67%-1.05M
46.25%-856.55K
-16.07%-6.55M
19.50%-1.48M
Minority interest income
Net income attributable to the parent company
58.63%-436.67K
-21.22%-1.27M
-39.53%-1.2M
36.90%-4.13M
20.98%-1.17M
-31.29%-1.06M
60.67%-1.05M
46.25%-856.55K
-16.07%-6.55M
19.50%-1.48M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
58.63%-436.67K
-21.22%-1.27M
-39.53%-1.2M
36.90%-4.13M
20.98%-1.17M
-31.29%-1.06M
60.67%-1.05M
46.25%-856.55K
-16.07%-6.55M
19.50%-1.48M
Basic earnings per share
59.42%-0.28
-20.29%-0.83
-39.29%-0.78
41.21%-2.71
20.62%-0.77
-23.21%-0.69
63.68%-0.69
53.33%-0.56
16.18%-4.61
30.71%-0.97
Diluted earnings per share
59.42%-0.28
-20.29%-0.83
-39.29%-0.78
41.21%-2.71
20.62%-0.77
-23.21%-0.69
63.68%-0.69
53.33%-0.56
16.18%-4.61
30.71%-0.97
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0.50%614.24K11.58%726.4K-15.69%510.82K48.80%2.54M37.99%671.96K47.54%611.17K56.22%651.01K55.75%605.84K47.06%1.71M46.41%486.97K
Operating revenue 0.50%614.24K11.58%726.4K-15.69%510.82K48.80%2.54M37.99%671.96K47.54%611.17K56.22%651.01K55.75%605.84K47.06%1.71M46.41%486.97K
Cost of revenue
Gross profit
Operating expense -36.64%1.11M11.61%2.06M16.98%1.78M-16.25%7.06M-5.98%1.93M39.29%1.76M-40.42%1.85M-24.28%1.52M21.97%8.42M-7.08%2.05M
Selling and administrative expenses 1.15%745.73K19.46%1.13M-9.81%834.91K-2.55%3.56M11.06%952K-14.60%737.24K-7.83%945.95K2.03%925.74K-2.40%3.65M-12.32%857.17K
-General and administrative expense 1.15%745.73K19.46%1.13M-9.81%834.91K-2.55%3.56M11.06%952K-14.60%737.24K-7.83%945.95K2.03%925.74K-2.40%3.65M-12.32%857.17K
Research and development costs -63.94%367.99K3.38%933.77K58.64%944.32K-26.75%3.49M-18.23%975.63K155.92%1.02M-56.52%903.24K-45.95%595.28K50.81%4.77M-2.92%1.19M
Operating profit 56.44%-499.47K-11.62%-1.34M-38.60%-1.27M32.78%-4.52M19.68%-1.26M-35.26%-1.15M55.41%-1.2M43.50%-915.18K-16.90%-6.72M16.58%-1.56M
Net non-operating interest income expense -33.22%61.3K-49.69%63.45K35.39%73.25K112.83%355.76K4.95%83.76K101.86%91.8K689.87%126.1K108.84%54.1K66.38%167.15K171.07%79.81K
Non-operating interest income -33.22%61.3K-49.69%63.45K35.39%73.25K112.83%355.76K4.95%83.76K101.86%91.8K689.87%126.1K108.84%54.1K66.38%167.15K171.07%79.81K
Other net income (expense) 325.83%1.5K-100.10%-21-98.85%521,689.23%25.38K-59.03%40460.96%-6662,063.01%21.12K2,171.36%4.52K-242.72%-1.6K-66.04%986
Other non- operating income (expenses) 325.83%1.5K-100.10%-21-98.85%521,689.23%25.38K-59.03%40460.96%-6662,063.01%21.12K2,171.36%4.52K-242.72%-1.6K-66.04%986
Income before tax 58.63%-436.67K-21.22%-1.27M-39.53%-1.2M36.90%-4.13M20.98%-1.17M-31.29%-1.06M60.67%-1.05M46.25%-856.55K-16.07%-6.55M19.50%-1.48M
Income tax
Net income 58.63%-436.67K-21.22%-1.27M-39.53%-1.2M36.90%-4.13M20.98%-1.17M-31.29%-1.06M60.67%-1.05M46.25%-856.55K-16.07%-6.55M19.50%-1.48M
Net income continuous Operations 58.63%-436.67K-21.22%-1.27M-39.53%-1.2M36.90%-4.13M20.98%-1.17M-31.29%-1.06M60.67%-1.05M46.25%-856.55K-16.07%-6.55M19.50%-1.48M
Minority interest income
Net income attributable to the parent company 58.63%-436.67K-21.22%-1.27M-39.53%-1.2M36.90%-4.13M20.98%-1.17M-31.29%-1.06M60.67%-1.05M46.25%-856.55K-16.07%-6.55M19.50%-1.48M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 58.63%-436.67K-21.22%-1.27M-39.53%-1.2M36.90%-4.13M20.98%-1.17M-31.29%-1.06M60.67%-1.05M46.25%-856.55K-16.07%-6.55M19.50%-1.48M
Basic earnings per share 59.42%-0.28-20.29%-0.83-39.29%-0.7841.21%-2.7120.62%-0.77-23.21%-0.6963.68%-0.6953.33%-0.5616.18%-4.6130.71%-0.97
Diluted earnings per share 59.42%-0.28-20.29%-0.83-39.29%-0.7841.21%-2.7120.62%-0.77-23.21%-0.6963.68%-0.6953.33%-0.5616.18%-4.6130.71%-0.97
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.